PGR and breast carcinoma: Here, we report the first in situ determination of a consensus PRE based on ChIP-seq data from 1,035 PR-binding sites in both breast cancer and leiomyoma cells: G•ACA•••TGT•C, which is consistent with the two previously reported motifs.